RICT 2017
Conferences > Upcoming events > RICT 2017
Wednesday July 5, 2017
08:00Registration & Welcome Coffee
09:30RICT 2017 Opening
Alexis VALENTIN (UNIVERSITÉ PAUL SABATIER, Toulouse, France)
Luc VAN HIJFTE (SCT & NOVITHERA, Illkirch, France)
Armand LATTES (UNIVERSITE PAUL SABATIER, Toulouse, France)
Session 1: Paul Ehrlich Award Lecture
Sponsored by Janssen Research & Development
Session Chairs
Jean-François BONFANTI (JANSSEN R&D, Val de Reuil, France)
Luc VAN HIJFTE (SCT & NOVITHERA, Illkirch, France)
10:00PL01 - Sugars & Proteins: Glycomimetics to Target Infectious Disease
Ben DAVIS
(OXFORD UNIVERSITY, Oxford, United Kingdom)
11:00Coffee break & Exhibition
Session 2: Peptides & Sugars in Drug Discovery
Session Chair
Olivier LAVERGNE
(IPSEN INNOVATION, Les Ulis, France)
11:30PL02 - Peptide Drugs to Target GPCR- State of the Art and Innovative Application
Annette BECK-SICKINGER
(LEIPZIG UNIVERSITY, Leipzig, Germany)
12:15Lunch break & Exhibition
13:00Poster Session 1 (odd numbers) & Exhibition
Session 3: Recent Advances in Immuno-oncology
Sponsored by Evotec
Session Chair
Gilbert LASSALLE
(EVOTEC, Toulouse, France)
14:30PL03 - Small Molecule Approaches in Immune Modulation in Cancer.
Ronan O'HAGAN
(MERCK, SHARP & DOHME, Boston, United States)
15:15PL04 - Immunotherapy of Cancers: The Lessons of Oncodermatology; Melanoma as a Model
Nicolas MEYER
(ONCOPOLE TOULOUSE, Toulouse, France)
16:00Coffee break & Exhibition
16:30PL05 - Novel Small Molecule MerTK Inhibitors and their Biological Uses
Xiaodong WANG
(UNIVERSITY OF NORTH CAROLINA, Chapel Hill, United States)
17:15PL06 - Discovery of PF-06840003, a Novel IDO Inhibitor for Cancer Immunotherapy
Stefano CROSIGNANI
(ITEOS THERAPEUTICS SA, Gosselies, Belgium)
18:00Welcome & Networking Reception
19:30End of Day 1
Thursday July 6, 2017
Session 4: Inspired by Nature
Session Chair
Michel BALTAS
(CNRS, UNIVERSITY OF TOULOUSE, Toulouse, France)
08:30PL07 - De Novo Drug Design — Inspiration from Nature
Gisbert SCHNEIDER
(ETH ZÜRICH, Zürich, Switzerland)
Session 4: Inspired by NatureSession 5: Advances in Kinase Inhibitors Discovery
Session Chair
Michel BALTAS
(CNRS, UNIVERSITY OF TOULOUSE, Toulouse, France)
09:15KL01 - New Modalities inspired by nature: from Genetic Encoding of Cyclic Peptides to Hybrid Macrocycles
Eric VALEUR
(ASTRAZENECA, Västra Frölunda, Sweden)
09:45KL03 - Post-functionalization of RNAs for Specific Conjugations with Peptides and Proteins
Mélanie ETHEVE-QUELQUEJEU
(UNIVERSITÉ PARIS DESCARTES, Paris, France)
Session Chair
Jean-Yves ORTHOLAND
(EDELRIS, Lyon, France)
09:15KL02 - Mnk1/2 Kinase Inhibitors for the Treatment of Leukemia
Kassoum NACRO
(EXPERIMENTAL THERAPEUTICS CENTER, Singapore, Singapore)
09:45KL04 - Discovery of CDK8/CDK19 Kinase Modulators and Evaluation of their Therapeutic Potential
Aurelie MALLINGER
(INSTITUTE OF CANCER RESEARCH, London, United Kingdom)
10:15Coffee break & Exhibition
Session 6: Accessing Novel Chemical SpaceSession 7: Structure Based Design
Session Chair
Janos SAPI
(SCT & UNIVERSITY OF REIMS-CHAMPAGNE-ARDENNE, Reims, France)
10:45PL08 - Expanding Screening Decks by Innovative MCR Scaffolds
Alexander DÖMLING
(UNIVERSITY OF GRONINGEN, Groningen, The Netherlands)
11:30PL10 - Chemoselective and Biocompatible Reactions, New Tools for Heterocyclic Chemistry and Chemical Biology
Frédéric TARAN
(CEA/SACLAY, Gif-sur-Yvette, France)
Session Chair
Jean-Paul RENAUD
(RIBOSTRUCT, Ostwald, France)
10:45PL09 - First-in-class Extracellular Modulators of Receptor Tyrosine Kinases: from Theory to Practice
Didier ROGNAN
(UNIVERSITY OF STRASBOURG, Illkirch, France)
11:30PL11 - Structure-based Drug Design (SBDD) in Medicinal Chemistry-enabled Drug Discovery
Hong SHEN
(F. HOFFMANN-LA ROCHE, Shanghai, China)
12:15Lunch break & Exhibition
13:00Poster Session 2 (even numbers) & Exhibition
13:45Career Session
Session 8: New Tools for Therapeutic InnovationSession 9: Advances in Proteases Inhibitor Discovery
Session Chair
YVES GENISSON
(UNIVERSITE PAUL SABATIER - LSPCMIB, Toulouse, France)
14:30KL05 - Copper and Zinc as Therapeutic Players in Alzheimer's Disease: With a little Help from Coordination Chemistry.
Christelle HUREAU
(LCC CNRS, Toulouse, France)
15:00KL07 - Nanometric Micelles for in vivo Imaging and Drug Delivery
Eric DORIS
(CEA, Gif-sur-Yvette, France)
Session Chair
Patrick JIMONET
(SANOFI, Vitry sur Seine, France)
14:30KL06 - Discovery of Novel TACE Inhibitors for Topical Treatment of Psoriasis
Gilles OUVRY
(GALDERMA R&D, Sophia Antipolis, France)
15:00KL08 - Mining from NP-Like Fragments in 3D: Discovery of a Potent Caspase-1 Inhibitor
Vincent RODESCHINI
(EDELRIS, Lyon, France)
Session 10: Rare DiseasesSession 11: Neglected Diseases
Session Chair
YVES GENISSON
(UNIVERSITE PAUL SABATIER - LSPCMIB, Toulouse, France)
15:30PL12 - Partnering Early to Better Serve Patients Suffering from Rare and Devastating Diseases
Jean-Philippe ANNEREAU
(ALEXION, Paris, France)
Session Chair
Patrick JIMONET
(SANOFI, Vitry sur Seine, France)
15:30PL13 - Allosteric Inhibitors of Dengue and Zika Virus NS3/NS2B Proteases
Tanja SCHIRMEISTER
(UNIVERSITY OF MAINZ, Mainz, Germany)
16:15Coffee break & Exhibition
Session 12: Synthetic BiologySession 13: Tackling PPIs
Session Chair
Sebastien PAPOT
(UNIVERSITY OF POITIERS, Poitiers, France)
16:45PL14 - Xeno Nucleic Acids (XNA) in vivo : A New Medicinal Chemistry Approach?
Piet HERDEWIJN
(KU LEUVEN, Leuven, Belgium)
17:30PL16 - Bioactive Ribosomal and Non-Ribosomal Peptides from Nature - Structures, Biosynthesis and Engineering Options
Roderich D. SÜSSMUTH
(TECHNICAL UNIVERSITY BERLIN, Berlin, Germany)
Session Chair
András KOTSCHY
(SERVIER RESEARCH INSTITUTE OF MEDICINAL CHEMISTRY, Budapest, Hungary)
16:45PL15 - Monitoring the Antagonist-Protein and Protein-Protein Interactions with NMR and X-ray: Inhibitors of the p53-Mdm2 and Immune Checkpoint PD-1/PD-L1 Interactions
Tad HOLAK
(MAX PLANCK INSTITUTE OF BIOCHEMISTRY, Martinsried, Germany)
17:30PL17 - Engineering Alphabodies to Generate Potent Druggable Inhibitors of Intracellular Protein-Protein Interactions
Ignace LASTERS
(COMPLIX, Zwijnaarde, Belgium)
18:15End of Day 2
19:00Cocktail at the City Hall
20:30Gala Dinner
Friday July 7, 2017
Session 14: Advances in Kinase Inhibitors Discovery & Development
Sponsored by Galapagos
Session Chair
Romain GOSMINI
(GALAPAGOS, Romainville, France)
08:30PL18 - Development of Dual IGF1R/INSR Inhibitors - A Case Study
Heather TYE
(EVOTEC LTD, Abingdon, United Kingdom)
09:15PL19 - Identifying High Quality, Potent and Selective Inhibitors of ATM Kinase for Oncology Therapies: Discovery of AZD0156
Bernard BARLAAM
(ASTRAZENECA, Macclesfield, United Kingdom)
10:00Coffee break & Exhibition
10:30PL20 - Raising the Gold Standard: Design & Development of Highly Selective JAK3 Probes (Janus Kinase 3)
Stefan LAUFER
(UNIVERSITY TÜBINGEN, Tübingen, Germany)
11:15PL21 - Leniolisib (CDZ173) - Discovery of a New Generation of Potent and Selective PI3Kδ Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases
Nicolas SOLDERMANN
(NOVARTIS, Basel, Switzerland)
Session 15: Pierre Fabre Award Lecture
Sponsored by Institut de Recherche Pierre Fabre
Session Chair
Michel PEREZ
(PIERRE FABRE, Toulouse, France)
12:00PL22 - Creating, Varying and Selecting : The Driving Forces in Drug Discovery and Chemical Biology Pierre Fabre Award lecture
Benoit DEPREZ
(UNIVERSITY OF LILLE 2, Lille, France)
13:00RICT 2017 Closing remarks & Prizes (Reaxys Award, Poster Prizes)
Sebastien PAPOT
(UNIVERSITY OF POITIERS, Poitiers, France)
13:15Introduction to RICT 2018
Dominique BONNET
(UNIVERSITY OF STRASBOURG, Illkirch, France)
13:30End of symposium
14:45Optional visit of the Airbus Facilities

Copyright 2017 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys